CVRX - CVRx Announces Key Senior Leadership Team Hires | Benzinga
- Dr. Philip B. Adamson will join as Chief Medical Officer
- Bonnie Handke will join as Senior Vice President of Patient Access, Reimbursement, and Healthcare Economics
- Jennifer E. Englund joins as Senior Vice President of Global Clinical Affairs
MINNEAPOLIS, May 16, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ:CVRX) ("CVRx"), a commercial-stage medical device company, today announced three additions to its senior leadership team. Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) has been appointed as Chief Medical Officer, Bonnie Handke, RN, MBA will assume the role of Senior Vice President of Patient Access, Reimbursement, and Healthcare Economics, and Jennifer E. Englund recently joined as Senior Vice President of Global Clinical Affairs. These roles will focus on driving the adoption of the company's Barostim™ therapy and expanding patient access.
"We are thrilled to welcome Dr. Adamson, Bonnie, and Jennifer to the CVRx leadership team. These three executives will play an important role as we seek to move our Barostim therapy towards standard of care," said Kevin Hykes, President and CEO of CVRx. "Dr. Adamson's deep expertise and relationships within the clinical community will be invaluable as we seek to drive awareness and appropriate adoption among clinicians. Bonnie's extensive experience in developing and executing market access strategies will be central in our efforts to expand patient access and secure favorable reimbursement. Jennifer's proven track record in leading successful clinical evidence generation strategies will be instrumental in ...